Gerald L. Chan
Gerald Chan is the co-founder of Morningside, a private investment group with venture capital , private equity and property investments.
Combining his training in science and experience in investments, Gerald has led the start-up of many biotechnology companies. His investments enabled many pioneering technologies in oncology including oncolytic viruses (Biovex, DNATrix), immuno-oncology (Aduro), novel cytotoxic agents (Nucana), modified tumor microenvironment (Vigeo) and novel targets for therapeutic intervention (CellCentric, K-Gen). Investments in the infectious disease area include novel antibiotics (MicuRx, Artugen), prophylactic vaccines (Matrivax) and antiviral small molecule drugs (Atea). Other investments cover the therapeutic areas of metabolic diseases (CVI, Alms), autoimmune diseases (Kezar), CNS disorders (Orthogonal, Pinteon, Cognito, Cognoa, Amylyx), and rare orphan diseases (Stealth, Apellis).
Gerald is a member of Harvard University’s Global Advisory Council, the Dean's Board of Advisors of the Harvard T.H. Chan School of Public Health and the Harvard China Fund . He chairs the Overseers Committee of the Morningside College of Chinese University of Hong Kong and the Innovation Advisory Committee of the Wellcome Trust in London.
Gerald received his BS and MS degrees in engineering from UCLA, his Master's degree in medical radiological physics and Doctor of Science degree in radiation biology from Harvard University. He did his post-doctoral training at the Dana-Farber Cancer Institute. The Chinese University of Hong Kong, University of Glasgow , Hong Kong University of Science and Technology, Scripps Research Institute and University of Massachusetts Boston have conferred on him honorary degrees. He was elected to an honorary fellowship at Wolfson College of Oxford University.
Mr. Lin is a partner of Davis Polk & Wardwell, the international law firm. Qualified to practice law in Hong Kong and New York, Mr. Lin has extensive experience advising on some of the most complex equity and debt capital markets and mergers and acquisitions transactions in Asia. He has advised leading new economy companies on their listings on The Stock Exchange of Hong Kong Limited, the Nasdaq Global Market and the New York Stock Exchange.
Mr. Lin holds a number of advisory and public roles. He is a Non-Executive Director of the Hong Kong Securities and Futures Commission. He is also currently serving on the Share Registrars’ Disciplinary Committee, Disciplinary Panel A of the Hong Kong Institute of Certified Public Accountants and the Process Review Panel in relation to the Regulation of MPF Intermediaries. He has previously served as a member of the Securities and Futures Appeals Tribunal and the Appeal Panel (Housing).
Mr. Lin attained his J.D. degree from Harvard Law School and A.B. degree from Harvard University. He also received his M.Phil and D.Phil degrees in International Relations from the University of Oxford (St. John’s College), where he was a Rotary Scholar.
Mr. Lin is also a Visiting Lecturer of Harvard Law School where he teaches a course on “Entrepreneurship, Venture Capital and Law in China” and serves on the Dean’s Asia Leadership Council.
Born and raised in Hong Kong, Sebastian Man is the Chairman and CEO of Chung Mei International Holdings Limited. Chung Mei Industries Limited, under the flagship Chung Mei International Holdings Limited, is a manufacturer of small household electrical appliances for major international brands.
Apart from business activities, Sebastian is involved in many community activities. He is particularly dedicated to education. He was the Co-President of the Harvard Business School Association of Hong Kong from 2006 to 2008 and is now a Director of the Association. He served on the Harvard Business School Global Alumni Board from 2012 to 2015. He is currently on the Board of the MIT Corporation Development Committee and the MIT HK Innovation Node Advisory Board. He has served two 6-year terms as trustee of his high school, Cate School, California, USA. He is a Court member of HKU.
Sebastian is an Executive Committee Member of the International Chamber of Commerce (ICC), Hong Kong China Business Council and a director of Pacific Basin Economic Council (PBEC). He is in Vision 2047 Foundation and a Council Member of The Better Hong Kong Foundation. He is also a founding member of HK Professionals and Senior Executives Association.
Sebastian holds a BS and MS in Mechanical Engineering at MIT and his MBA at Harvard Business School.